“We know why we get up every day and work as hard as we do. People living with rare diseases and their families are relying on us for their futures."
"We have this culture of innovating. And I don't just mean the science but also on healthcare policy. Everything we do is pretty unprecedented.”
"From my very early conversations with the Sarepta team, it was apparent that patient focus was real at Sarepta, and not simply a convenient phrase. I was in and decided to come out of retirement to do what I love at a company where the vision and ambition around patient care matched my own.”
“Science and the opportunity to impact patients’ lives for the better have always been the driving force behind every professional decision I’ve made. As I look back on those decisions, what makes Sarepta different from other companies is its tenacity and resilience.”
“Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. And I thought, imagine how I’ll feel if we can reach more kids. That’s why I ended up joining Sarepta.”
"Sarepta embodies the sense of mission that can be found in biotech, but here, it’s more robust. You can feel the spirit on a daily basis."
"The trajectory of Sarepta’s success has been built on three fundamental principles: do what’s best for the patient; grow aggressively, but prudently; and attract the right people who are driven to execute today, but who are also able to look around the corner for tomorrow’s opportunities."
“One of the biggest things that people will mention when they interview here is that they’re looking to make an impact. When people say that, we make sure they understand we have to do things faster, better—different than the traditional way. We have to have unconventional thinking in order to get things done.”
“I met the parents of a young boy with Duchenne muscular dystrophy. They said, ‘We’re so grateful you’re developing this gene therapy, but we’re really worried because our son is deteriorating fast.’ Well, we have a sort of sacred responsibility to help him and all the other boys he represents. We cannot stumble. We cannot slow down. We all feel that urgency here.”
“I’m here to bring gene therapy to life. We have to be creative; we need to transform the paradigm. There isn’t a path to guide us. We’re making the path.”